Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

NCT02145611 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Hypertension
Endothelial Dysfunction

Interventions

DRUG: Glibenclamide
DRUG: Vildagliptin

Sponsor

Dr. José Fernando Vilela-Martin MD PhD

Collaborators

[object Object]